Investors / China / Pan-Lin Capital
Pan-Lin Capital
Venture capital · Shanghai, China · Asia Pacific
Pan-Lin Capital is a Chinese venture capital firm founded in 2010 that invests in healthcare and biotech as well as AI and technology. It manages over RMB 5 billion in assets and has backed more than 30 industry leaders and unicorns.
Invests inHealthcare & BiotechIndustrial & Manufacturing
In its own wordshealthcarebiotechaihardwaremedical devicessemiconductors
Your fit with Pan-Lin Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsPan-Lin Capital lists 21 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Series A, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (48%), Industrial & Manufacturing (22%) and Robotics & Hardware (9%). 78% of its companies are based in China. It invests most often alongside Legend Star, 122 West Ventures and Amand Ventures.
Counts come from funding rounds that name Pan-Lin Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Pan-Lin Capital's whole history. Rounds on record name 2 companies; its own site lists 21. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 50% |
| Series B | 0% |
| Growth | 50% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 60th | 25 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 82th | 48% in its largest sector |
| Reach | 78th | 5 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Legend Star | 2 |
| 122 West Ventures | 1 |
| Amand Ventures | 1 |
| Blue Ocean Capital Group | 1 |
| Boyuan Capital | 1 |
| Capital Today | 1 |
| Fundamentum | 1 |
| Nottingham Technology Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2095%
- No longer answers00%
- Points to another company15%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 48% | 15% |
| Industrial & Manufacturing | 22% | 7% |
| Robotics & Hardware | 9% | 1% |
| AI & Machine Learning | 9% | 18% |
| Enterprise Software | 4% | 8% |
| Education | 4% | 7% |
| Mobility & Logistics | 4% | 1% |
Co-investor network
who it backs companies with, and who they back togetherCompare Pan-Lin Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Pan-Lin Capital| Date | Company | Stage |
|---|---|---|
| 5 Nov 2026 | Series A |
Round details for Pan-Lin Capital
Amounts, full round histories and every co-investor in Pan-Lin Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
21 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company develops targeted therapies that harness the immune system and target specific molecular pathways to combat cancer. | Healthcare & Biotech | Portfolio page | ||
| Kangtai Biological develops and produces vaccines | Healthcare & Biotech | Portfolio page | ||
| The company designs and manufactures pressure-electric MEMS microphones | Industrial & Manufacturing | Portfolio page | ||
| Cothera Bioscience is a clinical stage biotech company developing therapeutics for previously undruggable oncology targets with high unmet medical needs. | Healthcare & Biotech | Portfolio page | ||
| Saitong Microelectronics designs and develops machine vision sensing sensors, especially 3D sensors | Robotics & Hardware | Portfolio page | ||
| Portfolio page | ||||
| GenFleet Therapeutics develops innovative drugs, focusing on unmet clinical needs in the fields of tumors and immune diseases. | Healthcare & Biotech | Portfolio page | ||
| The company focuses on the commercial vehicle field and is an internet data company driven by commercial vehicle big data and digital technology | Industrial & ManufacturingAI & Machine Learning | Portfolio page | ||
| Portfolio page | ||||
| Huarui Shuxin supplies RAID card solutions | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| Portfolio page | ||||
| Portfolio page | ||||
| Portfolio page | ||||
| The company develops and researches new ADC technologies for medical innovation and patient treatment. | Healthcare & Biotech | Portfolio page | ||
| The company provides a one-stop solution for medical device innovation and entrepreneurship, including technology services, shared platforms, and digital support. | Healthcare & Biotech | Portfolio page | ||
| The company provides 3D machine vision products and solutions for industrial automation, smart logistics, and mobile robots. | Industrial & ManufacturingRobotics & Hardware | Portfolio page | ||
| Ribo Life Science develops and industrializes RNA interference technology and small nucleic acid drugs | Healthcare & Biotech | Portfolio page | ||
| Sand.ai develops and provides AI models, including a unified audio-video generation model called MAGI-2 Preview. | AI & Machine Learning | Nov 2026Series A | Funding round | |
| Portfolio page | ||||
| Portfolio page |
About this data
site last read 5 Nov 2026- Site
- panlincap.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 2 Feb 2026
- Companies checked
- 21
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Pan-Lin Capital's profile as data
Pull Pan-Lin Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/panlincap.com
# also
GET /v1/firms/panlincap.com/portfolio
GET /v1/firms/panlincap.com/coinvestors
GET /v1/firms/panlincap.com/news